OcyonBio Seeks FDA ‘Gold Star’ For Puerto Rico Biosimilar Manufacturing

Recent Deal Signed With Reliance Life Sciences JV Biosimilar Solutions

In the wake of signing a drug transfer and development agreement with Biosimilar Solutions in the firms’ native Puerto Rico, OcyonBio’s CEO Robert Salcedo spoke with Generics Bulletin about the company’s ambitions to put the US territory on the map for biosimilars.

OcyonBio has acquired rights to seven products • Source: Shutterstock/bobby20

More from Biosimilars

More from Products